Lenacapavir could put the end of the HIV epidemic in reach — if the people who need it can access it. Here’s one way to make ...
A 10% rise in African ancestry lowered odds of moderate TB drug reactions, while a 10% increase in European ancestry raised ...
Systemic candidiasis is an opportunistic fungal infection that has been difficult to treat effectively. Research published in ...
AI predicted that a forgotten breast cancer drug could be repurposed to treat many respiratory and gastrointestinal viruses, ...
Infliximab, subcutaneous anti-TNF agents, and ustekinumab show comparable effectiveness as second-line therapies in patients with ulcerative colitis after vedolizumab failure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results